JP2013544799A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544799A5
JP2013544799A5 JP2013535215A JP2013535215A JP2013544799A5 JP 2013544799 A5 JP2013544799 A5 JP 2013544799A5 JP 2013535215 A JP2013535215 A JP 2013535215A JP 2013535215 A JP2013535215 A JP 2013535215A JP 2013544799 A5 JP2013544799 A5 JP 2013544799A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
compound
pharmaceutical composition
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013535215A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013544799A (ja
JP6007186B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2011/001179 external-priority patent/WO2012097427A1/en
Publication of JP2013544799A publication Critical patent/JP2013544799A/ja
Publication of JP2013544799A5 publication Critical patent/JP2013544799A5/ja
Application granted granted Critical
Publication of JP6007186B2 publication Critical patent/JP6007186B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013535215A 2010-10-27 2011-10-26 がん治療のための化合物および組成物 Expired - Fee Related JP6007186B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40706910P 2010-10-27 2010-10-27
US61/407,069 2010-10-27
PCT/CA2011/001179 WO2012097427A1 (en) 2010-10-27 2011-10-26 Compounds and compositions for the treatment of cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016153378A Division JP6371344B2 (ja) 2010-10-27 2016-08-04 がん治療のための化合物および組成物

Publications (3)

Publication Number Publication Date
JP2013544799A JP2013544799A (ja) 2013-12-19
JP2013544799A5 true JP2013544799A5 (enExample) 2014-12-11
JP6007186B2 JP6007186B2 (ja) 2016-10-12

Family

ID=46515034

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013535215A Expired - Fee Related JP6007186B2 (ja) 2010-10-27 2011-10-26 がん治療のための化合物および組成物
JP2016153378A Expired - Fee Related JP6371344B2 (ja) 2010-10-27 2016-08-04 がん治療のための化合物および組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016153378A Expired - Fee Related JP6371344B2 (ja) 2010-10-27 2016-08-04 がん治療のための化合物および組成物

Country Status (24)

Country Link
US (2) US9114118B2 (enExample)
EP (2) EP2632452B1 (enExample)
JP (2) JP6007186B2 (enExample)
KR (2) KR101943280B1 (enExample)
CN (2) CN103347509B (enExample)
AU (2) AU2011356583C1 (enExample)
BR (1) BR112013010507A2 (enExample)
CA (1) CA2816093C (enExample)
CL (1) CL2013001152A1 (enExample)
DK (2) DK3443957T3 (enExample)
EA (2) EA035494B1 (enExample)
ES (2) ES2703257T3 (enExample)
IL (2) IL225599A (enExample)
MX (2) MX381345B (enExample)
MY (2) MY184343A (enExample)
NZ (1) NZ610851A (enExample)
PH (2) PH12013500766B1 (enExample)
PL (2) PL3443957T3 (enExample)
PT (2) PT2632452T (enExample)
SG (2) SG10201807622WA (enExample)
TR (1) TR201819987T4 (enExample)
TW (2) TWI620563B (enExample)
WO (1) WO2012097427A1 (enExample)
ZA (1) ZA201303035B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA035494B1 (ru) * 2010-10-27 2020-06-25 Прометик Фарма Смт Лимитед Способ и применение композиции для ингибирования миграции клеток опухоли и образования метастазов
TWI742541B (zh) * 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
RU2560702C1 (ru) * 2014-06-05 2015-08-20 Общество с ограниченной ответственностью "Научно-производственный центр "Амфион" (ООО "НПЦ "Амфион") Фармацевтическая композиция для применения в онкологии
BR112017007386A2 (pt) * 2014-10-10 2018-01-23 Prometic Pharma Smt Limited compostos de carboxilato fenilcetona e composições farmacêuticas para prevenção e tratamento de osteoporose
CA2963354A1 (en) * 2014-10-10 2016-04-14 Prometic Biosciences Inc. Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
TWI723967B (zh) * 2014-11-12 2021-04-11 英商邊緣生物科技有限公司 用於組織自修復及再生之經取代芳族化合物及醫藥組合物
CN106267213A (zh) * 2015-05-27 2017-01-04 聊城市奥润生物医药科技有限公司 环二核苷酸cGAMP在治疗肿瘤联合用药中的应用
SG10201913998YA (en) 2017-07-25 2020-03-30 Taris Biomedical Llc Methods of treating tumor metastasis
CN111787926A (zh) 2017-11-08 2020-10-16 塔里斯生物医药公司 使用吉西他滨对膀胱癌进行治疗和维持疗法的方法
EP3890717A4 (en) * 2018-12-05 2022-08-24 Liminal Biosciences Limited USE OF SODIUM 2-(3-PENTYLPHENYL)ACETATE IN THE TREATMENT OF ALSTRÖM SYNDROME
US11246945B2 (en) 2019-06-07 2022-02-15 National Defense Medical Center Cisplatin-loaded microbubbles, pharmaceutical composition for treatment of cancer, method for preparing pharmaceutical compositions and method for treating cancer
TW202532387A (zh) 2019-07-26 2025-08-16 美商艾斯佩維他治療學公司 官能化的長鏈烴一元及二元羧酸及其用於預防或治療疾病的用途
MX2023004137A (es) * 2020-10-06 2023-06-22 Pharmaceutique Ingenew Inc Compuestos aromaticos sustituidos y composiciones farmaceuticas de los mismos.
CA3209453A1 (en) 2021-01-25 2022-07-28 Espervita Therapeutics, Inc. Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives therof, and their use for the prevention or treatment of disease
CN114436822B (zh) * 2022-01-12 2024-04-16 厦门稀土材料研究所 一枝蒿酮酸和生物碱复盐及其制备方法和用途
EP4683624A1 (en) * 2023-03-22 2026-01-28 UTI Limited Partnership Hydroxyphenyl propanoate compounds for tumour immunotherapy, compositions and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0268907A3 (en) * 1986-11-19 1990-03-21 Carl Richard Thornfeldt Treatment of disease conditions relating to hyperactive organelles
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
ITMI20012434A1 (it) * 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono
CN1169768C (zh) * 2002-04-26 2004-10-06 中国科学院上海有机化学研究所 (4-炔基)-芳香酮酸类化合物、合成方法及应用
AU2003303460A1 (en) * 2002-12-27 2004-07-22 Tibotec Bvba Fluorogenic enzyme substrates and methods of preparation
WO2005009104A2 (en) * 2003-07-16 2005-02-03 Ligand Pharmacueticals Incorporated Benzoic and phenyl acetic acid derivatives as hnf-4 modulators
WO2005010202A2 (en) * 2003-07-16 2005-02-03 Ligand Pharmacueticals Incorporated PHENYL ACETIC ACID DERIVATIVES AS HEPATOCYTE NUCLEAR FACTOR 4α (HNF-4α) MODULATOR COMPOUNDS
US8198328B2 (en) * 2004-01-21 2012-06-12 New York University Treatment of cancer using benzoic acid derivatives
EP2061452B1 (en) 2006-09-01 2011-10-26 Piramal Life Sciences Limited Anti cancer use of caffeic acid and derivatives
ES2657484T3 (es) * 2007-02-08 2018-03-05 Emisphere Technologies, Inc. Agentes de administración de ácido fenilalquilcarboxílico
MX338513B (es) * 2007-11-02 2016-04-20 Prometic Pharma Smt Ltd Acidos grasos de longitud de cadena mediana y gliceridos como agentes de nefroprotección.
WO2009055932A1 (en) * 2007-11-02 2009-05-07 Prometic Biosciences Inc. Substituted phenylpropionic acids as stimulators of hematopoiesis and erythropoiesis
CA2708679C (en) * 2007-12-19 2016-11-15 Prometic Biosciences Inc. Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer
KR20120090011A (ko) * 2009-05-04 2012-08-16 프로메틱 바이오사이언시즈 인코포레이티드 3-펜틸페닐아세트산의 염 및 이의 약학적 용도
PT2427416E (pt) * 2009-05-04 2016-06-15 Prometic Pharma Smt Ltd Compostos aromáticos substituídos e seus usos farmacêuticos
EA035494B1 (ru) * 2010-10-27 2020-06-25 Прометик Фарма Смт Лимитед Способ и применение композиции для ингибирования миграции клеток опухоли и образования метастазов

Similar Documents

Publication Publication Date Title
JP2013544799A5 (enExample)
JP2014528467A5 (enExample)
NZ610851A (en) Compounds and compositions for the treatment of cancer
JP2013507423A5 (enExample)
JP2018507197A5 (enExample)
MX2009004715A (es) Compuestos heterociclicos como agentes antiinflamatorios.
JP2016503414A5 (enExample)
JP2017528475A5 (enExample)
GEP201706639B (en) Heterocyclic compounds and uses thereof
JP2006504624A5 (enExample)
JP2008535902A5 (enExample)
JP2019529518A5 (enExample)
JP2015522650A5 (enExample)
JP2009543802A5 (enExample)
JP2016513737A5 (enExample)
NZ710745A (en) Pyrrolobenzodiazepines and conjugates thereof
SI2970216T1 (en) Biaryl-amide compounds as kinase inhibitors
JP2015531366A5 (enExample)
JP2011251990A5 (enExample)
JP2014518882A5 (enExample)
GEP201606540B (en) New indolizine derivatives, method for their preparation and pharmaceutical compositions containing thereof
JP2014524441A5 (enExample)
EP4275756A3 (en) Bipyrazole derivatives as jak inhibitors
RU2005118417A (ru) Комбинированное введение индолинона с химиотерапевтическим средством при нарушениях, вызванных клеточной пролиферацией
JP2015504081A5 (enExample)